26 related articles for article (PubMed ID: 3701)
1. [Drug information. Metoprolol (Seloken, Hässle)].
Kampmann JP
Ugeskr Laeger; 1975 Dec; 137(51):3046-7. PubMed ID: 837
[No Abstract] [Full Text] [Related]
2. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
[No Abstract] [Full Text] [Related]
3. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
[TBL] [Abstract][Full Text] [Related]
4. [Effect of metoprolol on systolic time in patients with stable angina pectoris].
Mosti G; Tomei G; Veltri M; Giusti C
Minerva Cardioangiol; 1979 Mar; 27(3):147-52. PubMed ID: 37463
[No Abstract] [Full Text] [Related]
5. The use of beta-adrenergic blockers in the treatment of angina and hypertension. A clinical symposium. 31st annual meeting, American College of Angiology and 21st annual meeting, International College of Angiology. San Antonio, Texas, November 6, 1984.
Angiology; 1986 Mar; 37(3 Pt 2):215-62. PubMed ID: 2871778
[No Abstract] [Full Text] [Related]
6. [Seloken (Metoprolol, Hässle)].
Hjemdahl P
Lakartidningen; 1976 Mar; 73(12):1092. PubMed ID: 3701
[No Abstract] [Full Text] [Related]
7. Comparative review of beta-blocking agents.
Jackson EA; Sullman SA
Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
[No Abstract] [Full Text] [Related]
8. Efficacy of celiprolol in hypertension and angina pectoris. Introduction.
Norris RJ
Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1195-6. PubMed ID: 1672600
[No Abstract] [Full Text] [Related]
9. [Therapy and differential therapy with beta sympathicolytic drugs].
Frisch P
Med Klin; 1975 Oct; 70(42):1682-7. PubMed ID: 241898
[No Abstract] [Full Text] [Related]
10. [What is assured in the therapy of angina pectoris and hypertension with beta receptor blockers?].
Rettig G
Internist (Berl); 1980 Dec; 21(12):711-7. PubMed ID: 6110642
[No Abstract] [Full Text] [Related]
11. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
Lancaster SG; Sorkin EM
Drugs; 1988 Sep; 36(3):256-85. PubMed ID: 2903820
[TBL] [Abstract][Full Text] [Related]
12. Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
Frishman WH; Goldberg RJ; Benfield P
Drugs; 1988 Jan; 35(1):1-21. PubMed ID: 2894292
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
